Melanoma genetics Laboratory Broadening the knowledge of the genetic basis of the melanoma susceptibility aiming at identifying the genetic traits responsible for an increased cancer risk, and therefore useful to identify the high-risk individuals to be referred to specific health surveillance.<\/em><\/p><\/div><\/div> Broadening the knowledge of the molecular alterations that occur during the progression of melanoma with the aim of identifying genetic markers useful in the prognosis and therapy of melanoma patients.<\/em><\/p><\/div><\/div>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t Permanent staff<\/strong><\/p> Ph.D students<\/strong><\/p> Fellows<\/strong><\/p> Homepage Degree in Biological Sciences at the University of Padova, Dr. Menin works as Research Assistant at the Immunology and Diagnostic Molecular Oncology Unit of IOV, where she leads the laboratory for the genetic studies and analyses of the cutaneous melanoma.Dr. Menin is faculty member of the School of Doctorate in Clinical and Experimental Oncology […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":25787,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"no-sidebar","site-content-layout":"plain-container","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ep_exclude_from_search":false,"footnotes":""},"page-tags":[],"sezione-pagina":[],"acf":[],"yoast_head":"\n
Immunology and Molecular Oncology Unit<\/strong>
Department of Clinical and Experimental Oncology<\/em><\/p>research activity<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
GENETIC RISK FACTORS FOR CUTANEOUS MELANOMA<\/h3>
MOLECULAR CLASSIFICATION OF CUTANEOUS MELANOMA AND MOLECULAR MARKERS FOR PREDICTION OF THE TARGETED THERAPY RESPONSE IN THE ADVANCED MELANOMA<\/h3>
team members<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Selected references<\/h2>